我国慢性病临床路径实施效果的横断历史研究  

A cross-sectional historical study of the implementation effect of clinical pathways for chronic diseases in China

作　　者：周佳佳 王军永[2] 刘霞[3] ZHOU Jiajia;WANG Junyong;LIU Xia(School of Economics and Management,Jiangxi University of Chinese Medicine,Nanchang 330004,Jiangxi,China;Institute of Chinese Medicine and Massive Health Development,Jiangxi University of Chinese Medicine,Nanchang,Jiangxi 330004,China;School of Chinese Medicine,Jiangxi University of Chinese Medicine,Nanchang 330004,Jiangxi,China)

机构地区：[1]江西中医药大学经济与管理学院,江西南昌330004 [2]江西中医药大学中医药与大健康发展研究院,江西南昌330004 [3]江西中医药大学中医学院,江西南昌330004

出　　处：《右江民族医学院学报》2025年第1期98-102,共5页Journal of Youjiang Medical University for Nationalities

基　　金：国家自然科学基金项目(72064023)。

摘　　要：目的调查我国慢性病临床路径实施效果的纵向变化趋势,分析其影响因素,为优化临床路径、提高临床路径应用价值提供参考。方法搜集并筛选我国2002年至2023年有关慢性病临床路径实施效果的期刊文献,运用横断历史元分析的方法进行研究。结果2002~2023年关于慢性病临床路径实施效果的文献数量呈现先增加后减少的趋势;慢性病实施临床路径后降低的住院费用、减少的住院天数和入径率均值随年份变迁无明显变化趋势,临床路径实施效果的变动量介于小效果量和中等效果量之间;不同病种的慢性病中,时间对乳腺癌临床路径实施效果有一定的预测作用。结论受临床路径实施效果测量指标的统一性和规范性、病种类别、样本量等因素的影响,慢性病临床路径实施效果变迁无明显变化趋势。建议通过统一测量工具、落实责任主体、加强差异化管理等措施,不断改善临床路径管理工作。Objective To investigate the longitudinal change trend of the implementation effect of clinical pathways for chronic diseases in China,analyze its influencing factors,and provide references for optimizing clinical pathways and enhancing their application value.Methods Journal articles related to the implementation effects of clinical pathways for chronic diseases in China from 2002 to 2023 were collected and screened,and a cross-sectional historical Meta-analysis approach was employed for the study.Results From 2002 to 2023,the number of articles on the implementation effects of clinical pathways for chronic diseases showed an initial increase followed by a decrease.There was no significant trend in the reduction of hospitalization costs,shortened length of stay,and average adherence rate after the implementation of clinical pathways for chronic diseases over the years.The variation in the implementation effects of clinical pathways ranged between small and medium effect sizes.Among chronic diseases of different types,time had a certain predictive effect on the implementation effects of clinical pathways for breast cancer.Conclusion Affected by factors such as the unity and standardization of measurement indicators for the implementation effect of clinical pathways,disease categories,and sample size,there is no obvious change trend in the implementation effect of clinical pathways for chronic diseases.It is recommended to continuously improve the management of clinical pathways through measures such as unifying measurement tools,implementing responsible entities,and strengthening differentiated management.

关 键 词：临床路径 横断历史元分析 慢性病 效果评价 

分 类 号：R472[医药卫生—护理学]